These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
705 related articles for article (PubMed ID: 9671307)
1. Truncating mutations of hSNF5/INI1 in aggressive paediatric cancer. Versteege I; Sévenet N; Lange J; Rousseau-Merck MF; Ambros P; Handgretinger R; Aurias A; Delattre O Nature; 1998 Jul; 394(6689):203-6. PubMed ID: 9671307 [TBL] [Abstract][Full Text] [Related]
2. Spectrum of hSNF5/INI1 somatic mutations in human cancer and genotype-phenotype correlations. Sévenet N; Lellouch-Tubiana A; Schofield D; Hoang-Xuan K; Gessler M; Birnbaum D; Jeanpierre C; Jouvet A; Delattre O Hum Mol Genet; 1999 Dec; 8(13):2359-68. PubMed ID: 10556283 [TBL] [Abstract][Full Text] [Related]
3. Aberrations of the hSNF5/INI1 gene are restricted to malignant rhabdoid tumors or atypical teratoid/rhabdoid tumors in pediatric solid tumors. Uno K; Takita J; Yokomori K; Tanaka Y; Ohta S; Shimada H; Gilles FH; Sugita K; Abe S; Sako M; Hashizume K; Hayashi Y Genes Chromosomes Cancer; 2002 May; 34(1):33-41. PubMed ID: 11921280 [TBL] [Abstract][Full Text] [Related]
4. hSNF5/INI1 inactivation is mainly associated with homozygous deletions and mitotic recombinations in rhabdoid tumors. Rousseau-Merck MF; Versteege I; Legrand I; Couturier J; Mairal A; Delattre O; Aurias A Cancer Res; 1999 Jul; 59(13):3152-6. PubMed ID: 10397258 [TBL] [Abstract][Full Text] [Related]
5. Alterations of the hSNF5/INI1 gene in central nervous system atypical teratoid/rhabdoid tumors and renal and extrarenal rhabdoid tumors. Biegel JA; Tan L; Zhang F; Wainwright L; Russo P; Rorke LB Clin Cancer Res; 2002 Nov; 8(11):3461-7. PubMed ID: 12429635 [TBL] [Abstract][Full Text] [Related]
6. Two single nucleotide polymorphisms of the hSNF5/INI1 gene. Mine N; Bando K; Utada Y; Nagai H; Araki T; Emi M J Hum Genet; 1999; 44(5):354-5. PubMed ID: 10496084 [TBL] [Abstract][Full Text] [Related]
7. Novel germ-line deletion of SNF5/INI1/SMARCB1 gene in neonate presenting with congenital malignant rhabdoid tumor of kidney and brain primitive neuroectodermal tumor. Kusafuka T; Miao J; Yoneda A; Kuroda S; Fukuzawa M Genes Chromosomes Cancer; 2004 Jun; 40(2):133-9. PubMed ID: 15101046 [TBL] [Abstract][Full Text] [Related]
8. Frequent deletion of hSNF5/INI1, a component of the SWI/SNF complex, in chronic myeloid leukemia. Grand F; Kulkarni S; Chase A; Goldman JM; Gordon M; Cross NC Cancer Res; 1999 Aug; 59(16):3870-4. PubMed ID: 10463572 [TBL] [Abstract][Full Text] [Related]
9. hSNF5/INI1-deficient tumours and rhabdoid tumours are convergent but not fully overlapping entities. Bourdeaut F; Fréneaux P; Thuille B; Lellouch-Tubiana A; Nicolas A; Couturier J; Pierron G; Sainte-Rose C; Bergeron C; Bouvier R; Rialland X; Laurence V; Michon J; Sastre-Garau X; Delattre O J Pathol; 2007 Feb; 211(3):323-30. PubMed ID: 17152049 [TBL] [Abstract][Full Text] [Related]
10. Frequent co-inactivation of the SWI/SNF subunits SMARCB1, SMARCA2 and PBRM1 in malignant rhabdoid tumours. Rao Q; Xia QY; Wang ZY; Li L; Shen Q; Shi SS; Wang X; Liu B; Wang YF; Shi QL; Ma HH; Lu ZF; He Y; Zhang RS; Yu B; Zhou XJ Histopathology; 2015 Jul; 67(1):121-9. PubMed ID: 25496315 [TBL] [Abstract][Full Text] [Related]
11. [Rhadboid tumours: hSNF/INI1 deficient cancers of early childhood with aggressive behaviour]. Bourdeaut F; Dufour C; Delattre O Bull Cancer; 2010 Jan; 97(1):37-45. PubMed ID: 20080459 [TBL] [Abstract][Full Text] [Related]
12. Constitutional mutations of the hSNF5/INI1 gene predispose to a variety of cancers. Sévenet N; Sheridan E; Amram D; Schneider P; Handgretinger R; Delattre O Am J Hum Genet; 1999 Nov; 65(5):1342-8. PubMed ID: 10521299 [TBL] [Abstract][Full Text] [Related]
13. RhoA-dependent regulation of cell migration by the tumor suppressor hSNF5/INI1. Caramel J; Quignon F; Delattre O Cancer Res; 2008 Aug; 68(15):6154-61. PubMed ID: 18676838 [TBL] [Abstract][Full Text] [Related]
14. Aurora A is a repressed effector target of the chromatin remodeling protein INI1/hSNF5 required for rhabdoid tumor cell survival. Lee S; Cimica V; Ramachandra N; Zagzag D; Kalpana GV Cancer Res; 2011 May; 71(9):3225-35. PubMed ID: 21521802 [TBL] [Abstract][Full Text] [Related]
15. Indications for a tumor suppressor gene at 22q11 involved in the pathogenesis of ependymal tumors and distinct from hSNF5/INI1. Kraus JA; de Millas W; Sörensen N; Herbold C; Schichor C; Tonn JC; Wiestler OD; von Deimling A; Pietsch T Acta Neuropathol; 2001 Jul; 102(1):69-74. PubMed ID: 11547953 [TBL] [Abstract][Full Text] [Related]
16. The requirement for SNF5/INI1 in adipocyte differentiation highlights new features of malignant rhabdoid tumors. Caramel J; Medjkane S; Quignon F; Delattre O Oncogene; 2008 Mar; 27(14):2035-44. PubMed ID: 17922027 [TBL] [Abstract][Full Text] [Related]
17. High-resolution genomic analysis suggests the absence of recurrent genomic alterations other than SMARCB1 aberrations in atypical teratoid/rhabdoid tumors. Hasselblatt M; Isken S; Linge A; Eikmeier K; Jeibmann A; Oyen F; Nagel I; Richter J; Bartelheim K; Kordes U; Schneppenheim R; Frühwald M; Siebert R; Paulus W Genes Chromosomes Cancer; 2013 Feb; 52(2):185-90. PubMed ID: 23074045 [TBL] [Abstract][Full Text] [Related]
18. A key role of the hSNF5/INI1 tumour suppressor in the control of the G1-S transition of the cell cycle. Versteege I; Medjkane S; Rouillard D; Delattre O Oncogene; 2002 Sep; 21(42):6403-12. PubMed ID: 12226744 [TBL] [Abstract][Full Text] [Related]
19. No evidence for hypermethylation of the hSNF5/INI1 promoter in pediatric rhabdoid tumors. Zhang F; Tan L; Wainwright LM; Bartolomei MS; Biegel JA Genes Chromosomes Cancer; 2002 Aug; 34(4):398-405. PubMed ID: 12112529 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 is overexpressed in atypical teratoid/rhabdoid tumor with hSNF5/INI1 gene inactivation. Fujisawa H; Misaki K; Takabatake Y; Hasegawa M; Yamashita J J Neurooncol; 2005 Jun; 73(2):117-24. PubMed ID: 15981100 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]